NASDAQ : PROK

ProKidney Corp. — Financial statements

Healthcare · Biotechnology · United States

Last price 1.295 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 391.51M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

ProKidney Corp. (PROK) reported revenue of 818.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue818.00K893.00K76.00K
Gross Profit818.00K893.00K76.00K
Selling, General & Admin47.12M51.78M50.76M44.81M70.94M8.86M
Research & Development130.91M114.12M127.67M106.71M82.07M46.26M
Operating Expenses178.03M165.90M178.43M151.52M153.01M55.11M
Operating Income-177.22M-165.01M-178.35M-151.52M-153.01M-55.11M
Interest Expense-19.00K-4.00K-9.00K-12.00K-215.00K
Interest & Investment Income10.46M13.81M19.75M22.08M5.98M2.00K
EBT Excluding Unusual Items-166.78M-151.20M-158.61M-129.45M-147.24M-55.11M
Asset Writedown-5.32M
Pretax Income-166.78M-151.20M-163.93M-129.45M-147.24M-55.11M
Income Tax Expense-1.02M414.00K-598.00K6.00M896.00K38.00K
Earnings From Continuing Operations-165.75M-151.61M-163.34M-135.45M-148.13M-55.15M
Minority Interest in Earnings81.59M82.63M102.15M99.98M40.10M
Net Income-84.16M-68.99M-61.19M-35.47M-108.03M-55.15M
Preferred Dividends & Other Adjustments-93.63M
Net Income to Common-84.16M-68.99M-61.19M-35.47M-14.40M-55.15M
Shares Outstanding (Basic)151.20M133.94M97.92M61.71M61.54M150.71M
Shares Outstanding (Diluted)151.20M133.94M97.92M61.71M61.54M150.71M
EPS (Basic)-0.56-0.52-0.62-0.57-0.23-0.37
EPS (Diluted)-0.56-0.52-0.62-0.57-0.23-0.37
Free Cash Flow-159.73M-135.31M-155.86M-124.27M-78.94M-55.49M
Free Cash Flow Per Share-1.06-1.01-1.59-2.01-1.28-0.37
Gross Margin100.00%100.00%100.00%
Operating Margin-21,664.55%-18,477.83%-234,673.68%
Profit Margin-10,288.39%-7,725.20%-80,507.89%
Free Cash Flow Margin-19,527.38%-15,152.63%-205,078.95%
EBITDA-170.37M-158.43M-172.92M-147.67M-149.97M-53.13M
D&A For EBITDA6.85M6.58M5.43M3.85M3.04M1.98M
EBIT-177.22M-165.01M-178.35M-151.52M-153.01M-55.11M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents74.87M108.54M99.12M60.65M490.25M20.56M
Short-Term Investments106.70M161.48M259.17M302.30M
Cash & Short-Term Investments181.56M270.02M358.29M362.95M490.25M20.56M
Other Receivables956.00K1.13M2.45M1.38M
Receivables956.00K1.13M2.45M1.38M
Prepaid Expenses6.48M6.73M15.70M9.81M13.08M6.69M
Other Current Assets772.00K2.80M19.45M9.00K1.38M25.00K
Total Current Assets189.77M280.68M395.88M374.15M504.72M27.27M
Property, Plant & Equipment59.25M54.90M45.19M46.41M13.06M12.60M
Other Intangible Assets213.00K428.00K
Total Assets249.02M335.57M441.07M420.55M518.00M40.30M
Accounts Payable1.61M940.00K3.63M5.10M3.04M2.83M
Accrued Expenses18.71M27.58M30.77M16.97M7.34M9.21M
Current Portion of Leases1.13M1.07M765.00K803.00K493.00K267.00K
Current Income Taxes Payable682.00K1.47M
Other Current Liabilities1.26M1.15M369.00K693.00K
Total Current Liabilities22.71M30.74M36.22M25.04M10.87M12.31M
Long-Term Leases2.39M2.96M2.47M3.61M1.91M1.07M
Other Long-Term Liabilities1.07M1.07M748.00K568.00K278.00K
Total Liabilities26.18M34.78M39.44M29.22M13.06M13.38M
Common Stock31.00K30.00K29.00K23.00K24.00K188.43M
Additional Paid-In Capital434.76M258.55M205.74M36.11M7.48M
Retained Earnings-1.32B-1.27B-1.20B-1.14B-1.10B-161.51M
Comprehensive Income & Other-34.00K56.00K130.00K130.00K
Total Common Equity-883.53M-1.01B-994.95M-1.10B-1.10B26.92M
Minority Interest1.11B1.31B1.40B1.49B1.60B
Shareholders' Equity222.84M300.79M401.64M391.34M504.94M26.92M
Total Liabilities & Equity249.02M335.57M441.07M420.55M518.00M40.30M
Total Debt3.52M4.04M3.24M4.41M2.40M1.33M
Net Cash (Debt)178.04M265.98M355.06M358.54M487.85M19.22M
Net Cash Per Share1.181.993.635.817.930.13
Filing Date Shares Outstanding208.93M141.94M129.54M61.62M61.54M194.27M
Total Common Shares Outstanding205.72M141.81M128.05M59.88M61.54M194.27M
Working Capital167.06M249.94M359.67M349.11M493.85M14.96M
Book Value Per Share-4.29-7.13-7.77-18.43-17.820.14
Tangible Book Value-883.53M-1.01B-994.95M-1.10B-1.10B26.49M
Tangible Book Value Per Share-4.29-7.13-7.77-18.43-17.820.14
Land1.41M1.41M1.41M3.07M
Buildings21.09M21.09M21.09M22.49M
Machinery8.97M8.31M6.49M4.54M3.27M2.75M
Construction In Progress21.70M14.71M2.45M8.74M1.61M351.00K
Leasehold Improvements22.29M22.26M21.82M10.95M10.54M10.52M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-84.16M-68.99M-61.19M-35.47M-108.03M-55.15M
Depreciation & Amortization6.85M6.58M5.43M3.85M3.04M1.98M
Loss (Gain) From Sale of Assets967.00K1.43M56.00K23.00K
Asset Writedown & Restructuring Costs318.00K318.00K5.32M
Loss (Gain) From Sale of Investments-2.14M-3.42M-7.00M-6.02M
Stock-Based Compensation22.92M25.34M29.37M30.85M74.47M699.00K
Other Operating Activities-81.77M-82.66M-102.31M-99.98M-40.10M
Change in Accounts Payable-6.46M-5.92M11.59M11.64M494.00K7.87M
Change in Income Taxes170.00K-356.00K-609.00K1.76M278.00K
Change in Other Net Operating Assets2.14M7.56M-7.03M3.27M-7.23M-5.70M
Operating Cash Flow-141.17M-120.12M-126.35M-90.07M-77.09M-50.30M
Capital Expenditures-18.57M-15.20M-29.51M-34.20M-1.85M-5.19M
Sale of Property, Plant & Equipment18.21M18.21M1.00K
Investment in Securities105.10M100.95M49.92M-295.79M
Other Investing Activities108.00K
Investing Cash Flow104.74M103.97M20.41M-329.98M-1.74M-5.19M
Short-Term Debt Issued35.00M
Total Debt Issued35.00M
Short-Term Debt Repaid-35.00M
Long-Term Debt Repaid-26.00K-54.00K-52.00K-32.00K-30.00K
Total Debt Repaid-8.00K-26.00K-54.00K-52.00K-35.03M-30.00K
Net Debt Issued (Repaid)-8.00K-26.00K-54.00K-52.00K-32.00K-30.00K
Issuance of Common Stock26.36M25.59M144.46M6.05M71.50M
Repurchase of Common Stock-9.50M
Other Financing Activities542.50M
Financing Cash Flow26.35M25.57M144.41M-9.55M548.52M71.47M
Net Cash Flow-10.07M9.42M38.47M-429.60M469.69M15.98M
Free Cash Flow-159.73M-135.31M-155.86M-124.27M-78.94M-55.49M
Free Cash Flow Margin-19,527.38%-15,152.63%-205,078.95%
Free Cash Flow Per Share-1.06-1.01-1.59-2.01-1.28-0.37
Levered Free Cash Flow-83.84M-65.27M-121.36M-77.08M-29.53M-35.89M
Unlevered Free Cash Flow-83.83M-65.27M-121.35M-77.07M-29.39M-35.89M
Cash Income Tax Paid73.00K2.86M1.95M68.00K
Change in Working Capital-4.15M1.28M3.96M16.67M-6.46M2.16M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization301.69M317.06M216.27M119.50M422.17M315.71M
Enterprise Value123.65M1.38B1.24B1.25B1.53B
Last Close Price1.292.241.691.786.869.90
PS Ratio478.62355.052,845.61
PB Ratio1.761.050.540.300.8411.73
P/TBV Ratio11.92
EV/Sales Ratio260.961,540.8016,303.60
Debt / Equity Ratio0.020.010.010.010.010.05
Net Debt / Equity Ratio-0.80-0.88-0.88-0.92-0.97-0.71
Net Debt / EBITDA Ratio1.041.682.052.433.250.36
Net Debt / FCF Ratio1.111.972.282.886.180.35
Asset Turnover0.000.000.00
Quick Ratio8.048.829.9614.5545.091.67
Current Ratio8.369.1310.9314.9446.422.21
Return on Equity (ROE)-58.96%-43.17%-41.20%-30.22%-55.71%-299.86%
Return on Assets (ROA)-35.66%-26.56%-25.87%-20.18%-34.26%-120.86%
Return on Capital Employed (ROCE)-78.30%-54.10%-44.10%-38.30%-30.20%-196.90%
Earnings Yield-55.78%-21.76%-28.29%-29.68%-25.59%-17.47%
FCF Yield-40.80%-42.68%-72.07%-103.98%-18.70%-17.58%
Buyback Yield / Dilution-17.54%-36.79%-58.66%-0.28%59.17%-43.55%